Smith Salley Wealth Management Has $1.32 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Smith Salley Wealth Management reduced its position in Colgate-Palmolive (NYSE:CL) by 2.0% in the 4th quarter, HoldingsChannel reports. The firm owned 14,502 shares of the company’s stock after selling 290 shares during the period. Smith Salley Wealth Management’s holdings in Colgate-Palmolive were worth $1,318,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. D Orazio & Associates Inc. boosted its position in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after purchasing an additional 108 shares during the period. Fiducient Advisors LLC lifted its stake in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after buying an additional 110 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after buying an additional 113 shares during the period. Great Waters Wealth Management grew its stake in Colgate-Palmolive by 1.5% in the 3rd quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after buying an additional 117 shares during the last quarter. Finally, Waldron Private Wealth LLC raised its holdings in Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after acquiring an additional 118 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on CL shares. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $101.11.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $88.79 on Friday. The business has a fifty day simple moving average of $92.20 and a 200 day simple moving average of $97.74. The company has a market cap of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.37% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.